Fresh analysis suggests that people who stop using new weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt conventional lifestyle programs.
Research printed in a prominent health publication shows that while overweight people can lose about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Individuals using these treatments should be informed of the danger of rapid rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of recovery means a return to starting weight in about a year and a half.
Analyzing Therapies
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
The team emphasize that people who shed pounds through dieting usually have a slower creep back—approximately 100 grams monthly—post-intervention.
Understanding the Fast Regain
Doctors suggest the way of the jabs explains the heightened weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than normal could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the likelihood of relapse, the therapy is often long-term.
This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," akin to managing diseases like diabetes.
User Experiences
People who have discontinued the medication describe a powerful resurgence of appetite.
"It felt as if something activating and I was suddenly extremely hungry," said an individual.
This challenge is compounded if patients have not adopted sustainable lifestyle or habit changes during therapy.
Significant Adoption
Figures suggest that a significant number of people in the UK have tried these injections in the past year, with demand continuing to grow.
- Use is higher among females compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
Finally, clinicians stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a permanent solution and long-term success relies on ongoing lifestyle changes.
